These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 2773027)

  • 1. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Riccardi D; Cortellaro M; Ranzi ML; Sirchia G
    Transfusion; 1989 Sep; 29(7):605-9. PubMed ID: 2773027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of platelet function using the in vitro bleeding time and corrected count increment of transfused platelets. Comparison between platelet concentrates derived from pooled buffy coates and apheresis.
    Eriksson L; Kristensen J; Olsson K; Bring J; Högman CF
    Vox Sang; 1996; 70(2):69-75. PubMed ID: 8801766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet quality after 15-day storage of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium.
    Bertolini F; Rebulla P; Porretti L; Murphy S
    Transfusion; 1992 Jan; 32(1):9-16. PubMed ID: 1731448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet concentrates in an additive solution prepared from pooled buffy coats. In vivo studies.
    Eriksson L; Shanwell A; Gulliksson H; Högman CF; Svensson LA; Kristensen J; Berg B
    Vox Sang; 1993; 64(3):133-8. PubMed ID: 8484245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a 12-hour, 22 degrees C holding period for buffy coats on the preparation of platelet concentrates stored in plasma.
    Boeri N; Saleun S; Pelissier E; Saleun JP; Aiach M; Rendu F
    Transfusion; 1994 Oct; 34(10):881-6. PubMed ID: 7940660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vivo evaluation of random donor platelet concentrates from pooled buffy coats.
    Klüter H; Dörges L; Maass E; Wagner T; Bartels H; Kirchner H
    Ann Hematol; 1996 Aug; 73(2):85-9. PubMed ID: 8774617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse reactions to platelet transfusions are reduced by use of platelet concentrates derived from buffy coat.
    Oksanen K; Ebeling F; Kekomäki R; Elonen E; Sahlstedt L; Volin L; Myllylä G
    Vox Sang; 1994; 67(4):356-61. PubMed ID: 7701806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative assessment of prophylactic transfusions of platelet concentrates obtained by the PRP or buffy-coat methods, in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Fernández-Muñoz H; Plaza EM; Rivera-Caravaca JM; Candela MJ; Romera M; De Arriba F; Lozano ML; Vicente V; Heras I; Castilla-Llorente C; Rivera J
    Hematology; 2018 Oct; 23(9):712-718. PubMed ID: 29582705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet concentrates from buffy coats: improved conditions for preparation and evaluation in routine clinical use.
    Rebulla P; Bertolini F; Porretti L; Marangoni F; Smacchia C; Marconi M; Riccardi D; Sirelson V; Pappalettera M; Sirchia G
    Transfus Sci; 1993 Jan; 14(1):41-6. PubMed ID: 10148312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WBC-reduced platelet concentrates from pooled buffy coats in additive solution: an evaluation of in vitro and in vivo measures.
    van der Meer PF; Pietersz RN; Tiekstra MJ; Huijgens PC; Dekker WJ; Reesink HW
    Transfusion; 2001 Jul; 41(7):917-22. PubMed ID: 11452160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of the time of storage and transfusion reactions to platelet concentrates from buffy coats.
    Riccardi D; Raspollini E; Rebulla P; Pappalettera M; Marangoni F; Greppi N; Sirchia G
    Transfusion; 1997 May; 37(5):528-30. PubMed ID: 9149780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol opti system.
    Högman CF; Eriksson L; Wallvik J; Payrat JM
    Vox Sang; 1997; 73(4):212-9. PubMed ID: 9407638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet-rich plasma method.
    Muylle L; Wouters E; Peetermans ME
    Transfusion; 1996 Oct; 36(10):886-90. PubMed ID: 8863775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production.
    Levin E; Culibrk B; Gyöngyössy-Issa MI; Weiss S; Scammell K; LeFresne W; Jenkins C; Devine DV
    Transfusion; 2008 Nov; 48(11):2331-7. PubMed ID: 18631169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion of platelet concentrates--clinical evaluation of two preparations.
    Strindberg J; Berlin G
    Eur J Haematol; 1996 Oct; 57(4):307-11. PubMed ID: 8982294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paired comparison of platelet concentrates prepared from platelet-rich plasma and buffy coats using a new technique with 111In and 51Cr.
    Keegan T; Heaton A; Holme S; Owens M; Nelson E; Carmen R
    Transfusion; 1992 Feb; 32(2):113-20. PubMed ID: 1542917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality analysis of blood components obtained by automated buffy-coat layer removal with a top & bottom system (Optipress (R)II).
    Hurtado C; Bonanad S; Soler Mf; Mirabet V; Blasco I; Planelles Mf; De Miguel A
    Haematologica; 2000 Apr; 85(4):390-5. PubMed ID: 10756365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the quality of hemoderivatives obtained using a buffy-coat extraction system with a top-and-bottom technique (Optipress II)].
    Hurtado C; Bonanad S; Soler MA; Mirabet V; Blasco I; Planelles MD; de Miguel A
    Sangre (Barc); 1999 Oct; 44(5):319-26. PubMed ID: 10618907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods.
    Singh RP; Marwaha N; Malhotra P; Dash S
    Asian J Transfus Sci; 2009 Jul; 3(2):86-94. PubMed ID: 20808653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine generation in stored platelet concentrate: comparison of two methods of preparation.
    Chaudhary R; Aggarwal A; Khetan D; Dayal R
    Indian J Med Res; 2006 Oct; 124(4):427-30. PubMed ID: 17159263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.